[Idiopathic sudden sensorineural hearing loss. What's the appropriate management?].
BACKGROUND
Sudden sensorineural hearing loss remains a challenge in otology. Controverses affect mainly etiopathogeny and treatment.


OBJECTIVE
To evaluate our experience in the diagnosis and the treatment of sudden hearing loss


METHODS
We report a retrospective study, including 30 patients presenting a Sudden sensorineural hearing loss. All patients were hospitalized for treatment. The audiometry evaluated the hearing deafness before and after treatment.


RESULTS
The average age was of 48 years. In all the cases no etiology has been found. All The patients were hospitalized and corticotherapy was administrated in all cases. It was associated to hyperbare oxygenotherapy in 7 patients. Recovery was observed mainly in patients with moderate (71.4%) and severe hearing deficiency (69.2%).


CONCLUSIONS
Corticosteroids are the less controversed treatment of sudden sensorineural hearing loss.
Ben Gamra
Olfa
O
Service ORL & Chirurgie Cervico-Faciale, Hôpital Habib Thameur Tunis, Tunisie.
Mbarek
Chiraz
C
Ben Rejab
Imen
I
Hariga
Ines
I
Bhar
Hajer
H
Sghaier
Lamia
L
Zribi
S
S
El Khedim
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001301:Audiometry, Pure-Tone; D002648:Child; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006309:Hearing / Q000502:physiology; D003639:Hearing Loss, Sudden / Q000175:diagnosis / Q000628:therapy*; D006760:Hospitalization; D006801:Humans; D006931:Hyperbaric Oxygenation; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009257:Nafronyl / Q000627:therapeutic use; D010431:Pentoxifylline / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D020127:Recovery of Function / Q000502:physiology; D012189:Retrospective Studies; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D009257:Nafronyl; D001241:Aspirin; D010431:Pentoxifylline; D008775:Methylprednisolone